---
document_datetime: 2023-09-21 18:07:30
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/torisel-epar-all-authorised-presentations_en.pdf
document_name: torisel-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.689927
conversion_datetime: 2025-12-18 20:24:29.704254
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                               | Route of Administration   | Immediate Packaging   | Content (concentration)              | Pack size       |
|------------------|-------------------|------------|---------------------------------------------------|---------------------------|-----------------------|--------------------------------------|-----------------|
| EU/1/07/424/001  | Torisel           | 30 mg      | Concentrate and solvent for solution for infusion | Intravenous use           | vial (glass)          | concentrate: 1.2 ml; solvent: 1.8 ml | 1 vial + 1 vial |